
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical solution containing benzalkonium chloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing benzalkonium is listed. Products containing it are filed in the directory as over-the-counter monograph drugs, unapproved drugs and homeopathic products, in solution, liquid, cloth, soap and cream forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Benzalkonium chloride is a quaternary ammonium antiseptic and preservative applied to the skin, which a pharmacy may compound on a prescriber's order.
Benzalkonium chloride is a quaternary ammonium compound, a cationic surfactant. It kills bacteria by disrupting their cell membranes. It is the active ingredient in many over-the-counter products, such as first aid antiseptic towelettes labeled to help reduce the risk of infection in minor cuts, scrapes and burns, and antibacterial hand soaps and wipes. It is also used as a preservative in about 70% of ophthalmic formulations, according to a published review. A check of the FDA Drugs@FDA database found no NDA or ANDA product with benzalkonium chloride as an active ingredient; its products are marketed under FDA's over-the-counter monograph system. FDA has deferred a decision on benzalkonium chloride in consumer hand sanitizers pending new data. A prescriber might order it compounded in a form that is not sold over the counter. Compounded preparations are not FDA-approved and require a prescription.
Benzalkonium chloride products carry no boxed warning. The over-the-counter first aid antiseptic label says not to use it in the eyes or over large areas of the body, to stop use if irritation, redness or other symptoms develop, and to see a doctor if the problem persists or gets worse. Keep it out of reach of children; if swallowed, get medical help or contact a Poison Control Center right away. A review of poisonings in children found that swallowing it can cause corrosive injury to the esophagus and breathing problems. As an eye drop preservative, it can damage cells on the surface of the eye and has been linked to ocular surface disease symptoms. LactMed states that applying it to the skin, or its presence as a preservative in medicines, would not be expected to harm a breastfed infant. If you have a reaction, talk to your prescriber or pharmacist.
Benzalkonium chloride (BAK, BAC) is a cationic quaternary ammonium surfactant with hydrophilic and hydrophobic elements. Bactericidal activity follows interaction with bacterial cell membranes, causing membrane instability and lysis; it can also displace divalent cations from lipid bilayers of human cell membranes. Regulatory status: Drugs@FDA returned no application with benzalkonium chloride as an active ingredient. DailyMed lists more than 3,000 SPLs, for example the Dukal BZK towelette under OTC monograph M003 as a first aid antiseptic. FDA's 2019 consumer antiseptic rub final rule (84 FR 14847) deferred action on benzalkonium chloride to allow new safety and efficacy data, and 21 CFR 310.545 lists it as lacking adequate data for OTC dandruff, seborrheic dermatitis and psoriasis, insect bite and sting, and astringent uses. Ophthalmic: a review in Eye reports cytotoxic damage to conjunctival and corneal epithelial cells, ocular surface staining and higher ocular surface disease symptom scores, and notes it may act as a corneal penetration enhancer. Toxicology: ingestion produces corrosive injury resembling alkali exposure, with esophageal lesions reported in almost all published pediatric cases, and bronchoconstriction attributed to mast cell mediator release and cholinergic stimulation. Dosing is per prescriber. Benzalkonium chloride is not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin using the applicator provided or a cotton swab. Let it dry before covering. Use an accurate measuring device if your label gives a volume. Keep it away from the eyes and avoid open flame if the solution contains alcohol. Wash your hands afterward.
Topical solutions are aqueous or alcohol based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Keep the bottle tightly closed at room temperature, away from heat and flame, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)